Literature DB >> 9582370

Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S rRNA 3' end formation.

M W Briggs1, K T Burkard, J S Butler.   

Abstract

The eukaryotic 25 S, 18 S, and 5.8 S rRNAs are synthesized as a single transcript with two internal transcribed spacers (ITS1 and ITS2), which are removed by endo- and exoribonucleolytic steps to produce mature rRNA. Genetic selection for suppressors of a polyadenylation defect yielded two cold-sensitive alleles of a gene that we named RRP6 (ribosomal RNA processing). Molecular cloning of RRP6 revealed its homology to a 100-kDa human, nucleolar PM-Scl autoantigen and to Escherichia coli RNase D, a 3'-5' exoribonuclease. Recessive mutations in rrp6 result in the accumulation of a novel 5. 8 S rRNA processing intermediate, called 5.8 S*, which has normal 5' ends, but retains approximately 30 nucleotides of ITS2. Pulse-chase analysis of 5.8 S rRNA processing in an rrp6- strain revealed a precursor-product relationship between 5.8 S* and 5.8 S rRNAs, suggesting that Rrp6p plays a role in the removal of the last 30 nucleotides of ITS2 from 5.8 S precursors. A portion of 5.8 S* rRNA assembles into 60 S ribosomes which form polyribosomes, suggesting that they function in protein synthesis. These findings indicate that Rrp6p plays a role in 5.8 S rRNA 3' end formation, and they identify a functional intermediate in the rRNA processing pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582370     DOI: 10.1074/jbc.273.21.13255

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  154 in total

Review 1.  Protein trans-acting factors involved in ribosome biogenesis in Saccharomyces cerevisiae.

Authors:  D Kressler; P Linder; J de La Cruz
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Degradation of ribosomal RNA precursors by the exosome.

Authors:  C Allmang; P Mitchell; E Petfalski; D Tollervey
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

3.  Three conserved members of the RNase D family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast.

Authors:  A van Hoof; P Lennertz; R Parker
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

4.  Ski7p G protein interacts with the exosome and the Ski complex for 3'-to-5' mRNA decay in yeast.

Authors:  Y Araki; S Takahashi; T Kobayashi; H Kajiho; S Hoshino; T Katada
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 5.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 6.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

7.  Replication of avocado sunblotch viroid in the yeast Saccharomyces cerevisiae.

Authors:  Clémentine Delan-Forino; Marie-Christine Maurel; Claire Torchet
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

8.  Contribution of domain structure to the RNA 3' end processing and degradation functions of the nuclear exosome subunit Rrp6p.

Authors:  Seasson Phillips; J Scott Butler
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

9.  Rrp47p is an exosome-associated protein required for the 3' processing of stable RNAs.

Authors:  Philip Mitchell; Elisabeth Petfalski; Rym Houalla; Alexandre Podtelejnikov; Matthias Mann; David Tollervey
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs.

Authors:  Feng Fang; Jason Hoskins; J Scott Butler
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.